We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.50 | 0.40 | 0.55 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMMTFB TIDMAV.
RNS Number : 3869V
Motif Bio PLC
27 January 2017
Hot Features
Premium
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Motif Bio plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
---------------------------------------------------------------- ----------------------------------------
2. Reason for the notification (please tick the appropriate
box or boxes):
----------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
-------------------------------------------------------------------- ------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
-------------------------------------------------------------------- ------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
-------------------------------------------------------------------- ------------------------------------
An event changing the breakdown of voting rights
-------------------------------------------------------------------- ------------------------------------
Other (please
specify):
------------------------------------------------------------ ------ ------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
-------------------------------------------------------------- ------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
Available on Request 3,444*
BNY Norwich Union Nominees
Limited 299,767*
Chase (GA Group) Nominees
Limited 5,354,315*
State Street Nominees Limited
1,038,396*
*denotes direct interest
-------------------------------------------------------------- ------------------------------------------
5. Date of the transaction 23 January 2017
and date on
which the threshold is crossed
or
reached: (v)
-------------------------------------------------------------- ------------------------------------------
6. Date on which issuer notified: 24 January 2017
-------------------------------------------------------------- ------------------------------------------
7. Threshold(s) that is/are
crossed or <3% to >3% change at Direct
reached: (vi, vii) Interest Level (Box 8A)
-------------------------------------------------------------- ------------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
--------------- ----------------------------- --------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
--------------- -------------- ------------- ----------- ------------------------- ----------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
--------------- ------------- ------------ ----------- ---------- ------------- ------- -------------
Ordinary
Shares
8,924,647* 8,924,647* Not Not
GB00BVVT4H71 ** ** 6,695,922 6,695,922 Disclosable 3.42% Disclosable
-------------- ------------- ----------- ---------- ------------- ------- -------------
*Includes Right to Recall Loaned Shares (1,217,172)
** Includes indirect shares (2,028,725). The current
indirect share holding is not disclosable on this TR-1.
--------------------------------------------------------------------------------------------------------------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
---------------- -------------- ------------------------- ------------------------- ----------------------
200,000*
RIGHT TO RECALL
LOANED SHARES N/A N/A *Direct interest 0.10%
---------------- -------------- ------------------------- ------------------------- ----------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
6,895,922 3.52%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
--------------------------------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited & Friends Provident
International Limited, with the following chain of controlled
undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Friends Provident International Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
Proxy Voting:
--------------------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
----------------------------------------------- -------------------------------------
11. Number of voting rights proxy
holder will cease
to hold:
----------------------------------------------- -------------------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
----------------------------------------------- -------------------------------------
13. Additional information: Figures are based on the
revised total number of voting
rights of 195,885,228 as
per the Company's 'Issue
of Equity and Total Voting
Rights' announcement of 9
January 2017.
----------------------------------------------- -------------------------------------
14. Contact name: Neil Whittaker, Aviva plc
----------------------------------------------- -------------------------------------
15. Contact telephone number: 01603 684420
----------------------------------------------- -------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFLTLIIDFID
(END) Dow Jones Newswires
January 27, 2017 13:13 ET (18:13 GMT)
1 Year Motif Bio Chart |
1 Month Motif Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
